with an Overweight rating and a price target of $8.00. The new rating comes as KeyBanc analysts recognize the company's innovative Microbial Growth Direct System (GDS) as a significant advancement ...
Rapid Micro Biosystems Inc. (RPID) stock soared to a 52-week high, reaching a price level of $3.18 ... the company's innovative Microbial Growth Direct System (GDS) as a significant advancement ...
Recurring Revenue: $4.2 million, a 27% increase compared to the prior year quarter. Growth Direct System Placements: 6 systems placed in Q4, totaling 21 for the full year 2024. Cumulative System ...
Rapid Micro Biosystems and Merck KGaA have signed a five-year global distribution agreement for Growth Direct systems and consumables. Rapid Micro Biosystems, Inc. has entered a five-year global ...
Recurring Revenue: $4.2 million, a 27% increase compared to the prior year quarter. Growth Direct System Placements: 6 systems placed in Q4, totaling 21 for the full year 2024. Cumulative System ...